Literature DB >> 17133197

Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation.

Cynthia R Pearson1, Mark Micek, Jane M Simoni, Eduardo Matediana, Diane P Martin, Stephen Gloyd.   

Abstract

As resource-limited countries expand access to highly active antiretroviral therapy (HAART) treatment, innovative programs are needed to support adherence in the context of significant health system barriers. Modified directly observed therapy (mDOT) is one such strategy, but little is known about the process of designing and implementing mDOT programs for HAART in resource-limited settings. In this descriptive study, we used a mixed-methods approach to describe the process of implementing mDOT for an ongoing randomized control trial (RCT) in Beira, Mozambique. Interviews with clinic staff, mDOT peers, and participants provided information on design elements, problems with implementation, satisfaction, and benefits. Acceptability and feasibility measures were obtained from the RCT. Most (81%, N = 350) eligible persons agreed to participate, and of those randomized to mDOT (n = 174), 95% reported that their time with peers was beneficial. On average, participants kept 93% of the 30 required daily mDOT visits. Key components of the intervention's success included using peers who were well accepted by clinic staff, adequate training and retention of peers, adapting daily visit requirements to participants' work schedules and physical conditions, and reimbursing costs of transportation. This study identified aspects of mDOT that are effective and can be adopted by other clinics treating HIV patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17133197      PMCID: PMC5096448          DOI: 10.1097/01.qai.0000248339.82567.17

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  28 in total

Review 1.  Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.

Authors:  Jane M Simoni; Ann E Kurth; Cynthia R Pearson; David W Pantalone; Joseph O Merrill; Pamela A Frick
Journal:  AIDS Behav       Date:  2006-05

2.  Doubts about DOT: antiretroviral therapy for resource-poor countries.

Authors:  Cheryl A Liechty; David R Bangsberg
Journal:  AIDS       Date:  2003-06-13       Impact factor: 4.177

3.  Tuberculosis patient adherence to direct observation: results of a social study in Pakistan.

Authors:  M A Khan; J D Walley; S N Witter; S K Shah; S Javeed
Journal:  Health Policy Plan       Date:  2005-09-23       Impact factor: 3.344

4.  Costs and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan. Directly Observed Treatment.

Authors:  M A Khan; J D Walley; S N Witter; A Imran; N Safdar
Journal:  Health Policy Plan       Date:  2002-06       Impact factor: 3.344

5.  Treatment costs of directly observed therapy and traditional therapy for Mycobacterium tuberculosis: a comparative analysis.

Authors:  S E Weis; B Foresman; K J Matty; A Brown; F X Blais; G Burgess; B King; P E Cook; P C Slocum
Journal:  Int J Tuberc Lung Dis       Date:  1999-11       Impact factor: 2.373

6.  Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy).

Authors:  P Farmer; F Léandre; J Mukherjee; R Gupta; L Tarter; J Y Kim
Journal:  Bull World Health Organ       Date:  2001       Impact factor: 9.408

7.  Adherence is associated with the quality of professional-patient interaction in Directly Observed Treatment Short-course, DOTS.

Authors:  Pranaya Mishra; Ebba Holme Hansen; Svend Sabroe; Kumud Kumar Kafle
Journal:  Patient Educ Couns       Date:  2005-10-19

8.  Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience.

Authors:  Serena P Koenig; Fernet Léandre; Paul E Farmer
Journal:  AIDS       Date:  2004-06       Impact factor: 4.177

9.  Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.

Authors:  Carole Mitnick; Jaime Bayona; Eda Palacios; Sonya Shin; Jennifer Furin; Felix Alcántara; Epifanio Sánchez; Madeleny Sarria; Mercedes Becerra; Mary C Smith Fawzi; Saidi Kapiga; Donna Neuberg; James H Maguire; Jim Yong Kim; Paul Farmer
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

10.  Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.

Authors:  Gerald Friedland; Salim Abdool Karim; Quarraisha Abdool Karim; Umesh Lalloo; Christopher Jack; Neel Gandhi; Wafaa El Sadr
Journal:  Clin Infect Dis       Date:  2004-06-01       Impact factor: 9.079

View more
  19 in total

1.  Structural barriers to ART adherence in Southern Africa: Challenges and potential ways forward.

Authors:  A Kagee; R H Remien; A Berkman; S Hoffman; L Campos; L Swartz
Journal:  Glob Public Health       Date:  2011

2.  Access to antiretroviral therapy for adults and children with HIV infection in developing countries: Horizons studies, 2002-2008.

Authors:  Avina Sarna; Scott Kellerman
Journal:  Public Health Rep       Date:  2010 Mar-Apr       Impact factor: 2.792

3.  The Global HIV Archive: Facilitating the Transition from Science to Practice of Efficacious HIV Prevention Interventions.

Authors:  Josefina J Card; Emily N Newman; Rachel E Golden; Tamara Kuhn; Carmela Lomonaco
Journal:  World J AIDS       Date:  2013-03

Review 4.  Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.

Authors:  Jessica E Hart; Christie Y Jeon; Louise C Ivers; Heidi L Behforouz; Adolfo Caldas; Peter C Drobac; Sonya S Shin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

5.  How does directly observed therapy work? The mechanisms and impact of a comprehensive directly observed therapy intervention of highly active antiretroviral therapy in Peru.

Authors:  Sonya Shin; Maribel Muñoz; Jhon Zeladita; Sam Slavin; Adolfo Caldas; Eduardo Sanchez; Miriam Callacna; Christian Rojas; Jorge Arevalo; Jose Luis Sebastian; Jaime Bayona
Journal:  Health Soc Care Community       Date:  2010-12-08

6.  Sociocultural and epidemiological aspects of HIV/AIDS in Mozambique.

Authors:  Carolyn M Audet; Janeen Burlison; Troy D Moon; Mohsin Sidat; Alfredo E Vergara; Sten H Vermund
Journal:  BMC Int Health Hum Rights       Date:  2010-06-08

7.  One year after ART initiation: psychosocial factors associated with stigma among HIV-positive Mozambicans.

Authors:  C R Pearson; M A Micek; J Pfeiffer; P Montoya; E Matediane; T Jonasse; A Cunguara; D Rao; S S Gloyd
Journal:  AIDS Behav       Date:  2009-07-29

8.  Client Acceptability for Integrating Antiretroviral Therapy in Methadone Maintenance Therapy Clinics in Sichuan, China.

Authors:  Chunqing Lin; Li Li; Xiaobin Cao
Journal:  Subst Use Misuse       Date:  2016-09-28       Impact factor: 2.164

9.  Strategies for promoting adherence to antiretroviral therapy: a review of the literature.

Authors:  Jane M Simoni; K Rivet Amico; Cynthia R Pearson; Robert Malow
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

Review 10.  The information-motivation-behavioral skills model of antiretroviral adherence and its applications.

Authors:  Jeffrey D Fisher; K Rivet Amico; William A Fisher; Jennifer J Harman
Journal:  Curr HIV/AIDS Rep       Date:  2008-11       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.